Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Medical Operations Department	3.26B	3.44B	3.47B	2.75B	2.25B
Medical Operations Department Growth	-5.28%	-0.91%	26.21%	22.38%	39.04%
Optical Operation Department	1.09B	995.97M	880.79M	742.82M	619.00M
Optical Operation Department Growth	9.72%	13.08%	18.57%	20.00%	13.96%
Adjustment and Elimination	-147.80M	-208.48M	-270.87M	-	-235.27M
Total	4.20B	4.23B	4.08B	3.49B	2.63B
Total Growth	-0.57%	3.58%	16.83%	32.76%	28.18%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Taiwan	3.72B	3.63B	3.32B	2.69B	1.98B
Taiwan Growth	2.32%	9.33%	23.51%	35.69%	22.09%
Mainland China	485.05M	593.66M	757.79M	802.39M	648.17M
Mainland China Growth	-18.30%	-21.66%	-5.56%	23.79%	51.31%
Total	4.20B	4.23B	4.08B	3.49B	2.63B
Total Growth	-0.57%	3.58%	16.83%	32.76%	28.18%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 7, 2026

Data Sources Report a data error